Cogent Biosciences, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 1.2M | 1.2M | 0 | 1.2M | 0 | 0 | 0 | 0 |
| Gross Profit | -1.2M | -1.2M | 0 | -1.2M | 0 | 0 | 0 | 0 |
| R&D Expenses | 75.4M | 74.4M | 69.0M | 61.0M | 63.0M | 62.0M | 63.6M | 54.3M |
| Operating Expenses | 102.5M | 98.3M | 83.4M | 74.4M | 74.9M | 73.7M | 75.4M | 64.4M |
| Operating Income | -103.6M | -99.5M | -83.4M | -75.6M | -74.9M | -73.7M | -75.4M | -64.4M |
| Other Income / Gains | 6.3M | -3.0M | 2.4M | 2.1M | 2.9M | 5.8M | 4.8M | 5.4M |
| Net Income | -97.4M | -102.5M | -80.9M | -73.5M | -72.0M | -67.9M | -70.6M | -59.0M |
| EPS (Diluted) | -0.60 | -1.13 | -0.71 | -0.64 | -0.52 | -0.61 | -0.64 | -0.59 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 28.2M | 23.9M | 14.4M | 13.4M | 11.9M | 11.7M | 11.8M | 10.1M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 28.2M | 23.9M | 14.4M | 13.4M | 11.9M | 11.7M | 11.8M | 10.1M |
| Other Expenses | -1.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 103.6M | 99.5M | 83.4M | 75.6M | 74.9M | 73.7M | 75.4M | 64.4M |
| Interest Income | 7.6M | 5.5M | 3.9M | 2.4M | 3.0M | 3.9M | 4.8M | 5.4M |
| Interest Expense | 1.2M | 1.3M | 1.5M | 314K | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 1.2M | -2.9M | 641K | 1.2M | 1.1M | 1.1M | 1.1M | 1.1M |
| Ebitda | -102.5M | -108.7M | -78.8M | -72.1M | -73.8M | -72.6M | -74.3M | -57.9M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -97.4M | -102.5M | -80.9M | -73.5M | -72.0M | -67.9M | -70.6M | -59.0M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.60 | -1.13 | -0.71 | -0.64 | -0.52 | -0.61 | -0.64 | -0.59 |
| Weighted Average Shs Out | 67.4M | 67.6M | 114.5M | 114.5M | 113.3M | 110.5M | 110.2M | 99.2M |
| Weighted Average Shs Out Dil | 67.4M | 67.6M | 114.5M | 114.5M | 113.3M | 110.5M | 110.2M | 99.2M |